Home
About
Overview
Sharing Data
ORCID
Help
History (15)
Pharmacokinetics and pharmacodynamics of oltipraz as a chemopreventive agent.
Renal tumors in young adults.
Infectious proctitis: when to suspect it is not inflammatory bowel disease.
Concomitant radiation therapy and paclitaxel for unresectable locally advanced breast cancer: results from two consecutive phase I/II trials.
Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease.
See All 15 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease.
Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease. Diabetes Obes Metab. 2013 May; 15(5):463-73.
View in:
PubMed
subject areas
Aged
Biomarkers
Blood Glucose
Body Weight
Canagliflozin
Comorbidity
Diabetes Mellitus, Type 2
Disease Progression
Diuresis
Dose-Response Relationship, Drug
Double-Blind Method
Drug Administration Schedule
Female
Glomerular Filtration Rate
Glucosides
Humans
Hypoglycemic Agents
Male
Renal Insufficiency, Chronic
Sodium-Glucose Transporter 2
Thiophenes
Treatment Outcome
Urinary Tract Infections